Global In-situ Hybridization (ISH) Market 2017-2021

  • ID: 4339932
  • Report
  • Region: Global
  • 85 pages
  • TechNavio
OFF
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • Abbott
  • Agilent Technologies
  • Biocare Medical
  • BioGenex
  • Exiqon
  • Genemed Biotechnologies
  • MORE
About In-Situ Hybridization (ISH)

ISH is a technique for localizing specific nucleic acid targets within fixed tissues and cells, providing temporal and spatial information about gene expression and genetic loci. While the basic workflow of ISH is similar to that of blot hybridizations, the nucleic acid probe is synthesized, labeled, purified, and annealed with the specific target; the difference is the greater amount of information gained by visualizing the results within the tissue.

The analysts forecast the global in-situ hybridization (ISH) market to grow at a CAGR of 6.59% during the period 2017-2021.

Covered in this report
The report covers the present scenario and the growth prospects of the global in-situ hybridization (ISH) market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of reagents and instruments used to conduct ISH.

The market is divided into the following segments based on geography:
  • Americas
  • APAC
  • EMEA
The report, Global In-situ Hybridization (ISH) Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Abbott
  • Agilent Technologies
  • F. Hoffmann-La Roche
  • Thermo Fisher Scientific
Other prominent vendors
  • Advanced Cell Diagnostics
  • Biocare Medical
  • Bio SB
  • BioDot
  • BioGenex
  • Cytocell
  • Exiqon
  • Genemed Biotechnologies
  • LGC Biosearch Technologies
  • Leica Biosystems
  • Merck
  • Mirius Bio
  • PerkinElmer
Market drivers
  • Growing incidence and prevalence of cancer
  • For a full, detailed list, view the full report
Market challenges
  • Emergence of alternative techniques
  • For a full, detailed list, view the full report
Market trends
  • Increasing M&A activity in molecular diagnostics market
  • For a full, detailed list, view the full report
Key questions answered in this report
  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the Key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?
You can request one free hour of the analyst’s time when you purchase this market report. Details are provided within the report.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abbott
  • Agilent Technologies
  • Biocare Medical
  • BioGenex
  • Exiqon
  • Genemed Biotechnologies
  • MORE
PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction
  • Market outline
PART 05: Market landscape
  • Market size and forecast
  • Five forces analysis
PART 06: Market segmentation by technology
  • Market overview
  • FISH
  • CISH
PART 07: Market segmentation by end-user
  • Market overview
  • Molecular diagnostic laboratories
  • Pharmaceutical and biotechnology companies
  • Others
PART 08: Geographical segmentation
  • Market overview
  • ISH market in Americas
  • ISH market in EMEA
  • ISH market in APAC
PART 09: Decision framework

PART 10: Drivers and challenges
  • Market drivers
  • Market challenges
PART 11: Market trends
  • Increasing M&A activity in molecular diagnostics market
  • National initiatives across the globe spurring molecular research activities
  • Increasing importance of promotional activities
PART 12: Vendor landscape
  • Competitive scenario
  • Investment opportunity
PART 13: Key vendor analysis
  • Abbott
  • Agilent Technologies
  • F. Hoffmann-La Roche
  • Thermo Fisher Scientific
  • Other prominent vendors
PART 14: Appendix
  • List of abbreviations
List of Exhibits
Exhibit 01: Differences between CISH and FISH
Exhibit 02: Snapshot: Overview of global ISH market
Exhibit 03: Global ISH market 2016-2021 ($ millions)
Exhibit 04: Factors affecting global ISH market and their level of impact
Exhibit 05: Five forces analysis
Exhibit 06: Global ISH market by technology 2016 and 2021 (% share)
Exhibit 07: Snapshot: Overview of global ISH market by technology
Exhibit 08: Global FISH market 2016-2021 ($ millions)
Exhibit 09: Global CISH market 2016-2021 ($ millions)
Exhibit 10: Global ISH market by end-user 2016 and 2021 (% share)
Exhibit 11: Snapshot: Overview of global ISH market by end-user
Exhibit 12: Global ISH market by molecular diagnostic laboratories 2016-2021 ($ millions)
Exhibit 13: Global ISH market by pharmaceutical and biotechnology companies 2016-2021 ($ millions)
Exhibit 14: Global ISH market by others 2016-2021 ($ millions)
Exhibit 15: Global ISH market by geography 2016 and 2021 (% share)
Exhibit 16: Snapshot: Overview of global ISH market by geography
Exhibit 17: ISH market in Americas 2016-2021 ($ millions)
Exhibit 18: ISH market in EMEA 2016-2021 ($ millions)
Exhibit 19: ISH market in APAC 2016-2021 ($ millions)
Exhibit 20: List of FDA-approved companion diagnostic tests using ISH
Exhibit 21: Personalized medicine and key statistics from FDA approvals of NMEs
Exhibit 22: Advantages of FISH in detection of foodborne pathogens as compared with conventional methods
Exhibit 23: Head-to-head comparison between traditional FISH and DMI
Exhibit 24: Strategic success factors currently being followed by vendors
Exhibit 25: Investment opportunity mapping
Exhibit 26: Abbott: Profile
Exhibit 27: Abbott: Strength analysis
Exhibit 28: Abbott: Strategy assessment
Exhibit 29: Abbott: Opportunity assessment
Exhibit 30: Agilent Technologies: Profile
Exhibit 31: Agilent Technologies: Strength analysis
Exhibit 32: Agilent Technologies: Strategy assessment
Exhibit 33: Agilent Technologies: Opportunity assessment
Exhibit 34: F. Hoffmann-La Roche: Profile
Exhibit 35: F. Hoffmann-La Roche: Strength analysis
Exhibit 36: F. Hoffmann-La Roche: Strategy assessment
Exhibit 37: F. Hoffmann-La Roche: Opportunity assessment
Exhibit 38: Thermo Fisher Scientific: Profile
Exhibit 39: Thermo Fisher Scientific: Strength analysis
Exhibit 40: Thermo Fisher Scientific: Strategy assessment
Exhibit 41: Thermo Fisher Scientific: Opportunity assessment
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Abbott
  • Agilent Technologies
  • Biocare Medical
  • BioGenex
  • Exiqon
  • Genemed Biotechnologies
  • MORE
New Report Released: – Global In-situ Hybridization (ISH) Market 2017-2021

The author of the report recognizes the following companies as the key players in the global in-situ hybridization (ISH) market: Abbott, Agilent Technologies, F. Hoffmann-La Roche, and Thermo Fisher Scientific

Other Prominent Vendors in the market are: Advanced Cell Diagnostics, Biocare Medical, Bio SB, BioDot, BioGenex, Cytocell, Exiqon, Genemed Biotechnologies, LGC Biosearch Technologies, Leica Biosystems, Merck, Mirius Bio, and PerkinElmer.

Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is Increasing M&A activity in molecular diagnostics market. Diagnostic companies are progressively seeking strategic opportunities to enhance their competencies in the molecular diagnostics sector and tap into the market’s growth potential. The global molecular diagnostics market is poised to grow at a high rate and reach over $7 billion by 2022. Industry experts and KOLs believe that PCR, NGS, microarray, and ISH, especially FISH, are the dominant technologies in the space. Particularly for ISH, a major trend of partnerships is being observed as one company focuses on developing the therapy for a drug, while the other company focuses on developing the companion diagnostic test. Both companies benefit immensely from such deals as a synergistic growth opportunity is seen along with portfolio expansion.”

According to the report, one of the major drivers for this market is Growing incidence and prevalence of cancer. Globally, cancer is among the top five causes of death across all age groups. The various types of cancer contribute to significant deaths across all regions in the world. However, the low and middle-income countries are the worst-affected regions. Cancer caused by tobacco is the most common type of cancer in these countries, which is also the most-easily preventable.

Further, the report states that one of the major factors hindering the growth of this market is Emergence of alternative techniques. Although FISH provides considerable cost benefit and superior performance when compared with other molecular IVD tests, full-scale adoption of this technique is lacking in routine IVD use. When applied to complex samples such as mucoid respiratory samples, results are highly irregular and the procedure intrinsically complex. Although some advancements have been made which remove traditional DNA probes with peptide probes, the resulting IVD assays till date have only managed to address niche markets.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
  • Abbott
  • Agilent Technologies
  • F. Hoffmann-La Roche
  • Thermo Fisher Scientific
  • Advanced Cell Diagnostics
  • Biocare Medical
  • Bio SB
  • BioDot
  • BioGenex
  • Cytocell
  • Exiqon
  • Genemed Biotechnologies
  • LGC Biosearch Technologies
  • Leica Biosystems
  • Merck
  • Mirius Bio
  • PerkinElmer
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll